SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Adline Chem Lab - Quaterly Results

14 Feb 2022 Evaluate
The Sales for the quarter ended December 2021 of Rs. 0.84 million declined by -94.86% from Rs. 16.35 millions.The Net Loss for the quarter ended December 2021 is Rs. -2.10 millions as compared to Net Loss of Rs. -4.00 millions of corresponding quarter ended December 2020 Operating profit Margin for the quarter ended December 2021 improved to 0.46% as compared to -1.10% of corresponding quarter ended December 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 0.84 16.35 -94.86 7.16 42.56 -83.18 63.28 65.91 -3.99
Other Income 0.49 0.00 0.00 2.08 0.01 20700.00 0.03 0.23 -86.96
PBIDT 0.46 -1.10 -141.82 0.08 -1.33 -106.02 -2.26 -33.10 -93.17
Interest 0.00 0.03 0.00 0.04 0.09 -55.56 0.33 0.20 65.00
PBDT 0.46 -1.13 -140.71 0.04 -1.42 -102.82 -2.59 -30.87 -91.61
Depreciation 2.56 2.87 -10.80 7.68 8.61 -10.80 10.23 4.23 141.84
PBT -2.10 -4.00 -47.50 -7.64 -10.03 -23.83 -12.82 -35.10 -63.48
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.57 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.00
PAT -2.10 -4.00 -47.50 -7.64 -10.03 -23.83 -12.82 -37.67 -65.97
Equity 58.50 58.50 0.00 58.50 58.50 0.00 58.50 58.50 0.00
PBIDTM(%) 54.76 -6.73 -913.96 1.12 -3.13 -135.75 -3.57 -50.22 -92.89

Adline Chem Lab Share Price

13.70 0.00 (0.00%)
22-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.20
Dr. Reddys Lab 1279.90
Cipla 1382.40
Zydus Lifesciences 1099.55
Lupin 2273.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×